Literature DB >> 26338899

Simultaneous Hyperpolarized 13C-Pyruvate MRI and 18F-FDG PET (HyperPET) in 10 Dogs with Cancer.

Henrik Gutte1, Adam E Hansen1, Majbrit M E Larsen2, Sofie Rahbek1, Sarah T Henriksen3, Helle H Johannesen1, Jan Ardenkjaer-Larsen4, Annemarie T Kristensen2, Liselotte Højgaard1, Andreas Kjær1.   

Abstract

UNLABELLED: With the introduction of combined PET/MR spectroscopic (MRS) imaging, it is now possible to directly and indirectly image the Warburg effect with hyperpolarized (13)C-pyruvate and (18)F-FDG PET imaging, respectively, via a technique we have named hyperPET. The main purpose of this present study was to establish a practical workflow for performing (18)F-FDG PET and hyperpolarized (13)C-pyruvate MRS imaging simultaneously for tumor tissue characterization and on a larger scale test its feasibility. In addition, we evaluated the correlation between (18)F-FDG uptake and (13)C-lactate production.
METHODS: Ten dogs with biopsy-verified spontaneous malignant tumors were included for imaging. All dogs underwent a protocol of simultaneous (18)F-FDG PET, anatomic MR, and hyperpolarized dynamic nuclear polarization with (13)C-pyruvate imaging. The data were acquired using a combined clinical PET/MR imaging scanner.
RESULTS: We found that combined (18)F-FDG PET and (13)C-pyruvate MRS imaging was possible in a single session of approximately 2 h. A continuous workflow was obtained with the injection of (18)F-FDG when the dogs was placed in the PET/MR scanner. (13)C-MRS dynamic acquisition demonstrated in an axial slab increased (13)C-lactate production in 9 of 10 dogs. For the 9 dogs, the (13)C-lactate was detected after a mean of 25 s (range, 17-33 s), with a mean to peak of (13)C-lactate at 49 s (range, 40-62 s). (13)C-pyruvate could be detected on average after 13 s (range, 5-26 s) and peaked on average after 25 s (range, 13-42 s). We noticed concordance of (18)F-FDG uptake and production of (13)C-lactate in most, but not all, axial slices.
CONCLUSION: In this study, we have shown in a series of dogs with cancer that hyperPET can easily be performed within 2 h. We showed mostly correspondence between (13)C-lactate production and (18)F-FDG uptake and expect the combined modalities to reveal additional metabolic information to improve prognostic value and improve response monitoring.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  13C-pyruvate; 18F-FDG PET; MR; PET/MR; cancer; dynamic nuclear polarization; hyperpolarized; molecular imaging

Mesh:

Substances:

Year:  2015        PMID: 26338899     DOI: 10.2967/jnumed.115.156364

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  Hyperpolarized Metabolic Imaging Detects Latent Hepatocellular Carcinoma Domains Surviving Locoregional Therapy.

Authors:  Nicholas R Perkons; Ryan M Kiefer; Michael C Noji; Mehrdad Pourfathi; Daniel Ackerman; Sarmad Siddiqui; David Tischfield; Enri Profka; Omar Johnson; Stephen Pickup; Anthony Mancuso; Austin Pantel; Michelle R Denburg; Gregory J Nadolski; Stephen J Hunt; Emma E Furth; Stephen Kadlecek; Terence P F Gade
Journal:  Hepatology       Date:  2020-05-16       Impact factor: 17.425

Review 2.  Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.

Authors:  Fulvio Zaccagna; James T Grist; Surrin S Deen; Ramona Woitek; Laura Mt Lechermann; Mary A McLean; Bristi Basu; Ferdia A Gallagher
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

3.  Multimodality Hyperpolarized C-13 MRS/PET/Multiparametric MR Imaging for Detection and Image-Guided Biopsy of Prostate Cancer: First Experience in a Canine Prostate Cancer Model.

Authors:  Sunitha V Bachawal; Jae Mo Park; Keerthi S Valluru; Mathias Dyrberg Loft; Stephen A Felt; José G Vilches-Moure; Yamil F Saenz; Bruce Daniel; Andrei Iagaru; Geoffrey Sonn; Zhen Cheng; Daniel M Spielman; Jürgen K Willmann
Journal:  Mol Imaging Biol       Date:  2019-10       Impact factor: 3.488

Review 4.  Imaging Tumor Metabolism to Assess Disease Progression and Treatment Response.

Authors:  Kerstin N Timm; Brett W C Kennedy; Kevin M Brindle
Journal:  Clin Cancer Res       Date:  2016-09-08       Impact factor: 12.531

Review 5.  The use of dynamic nuclear polarization (13)C-pyruvate MRS in cancer.

Authors:  Henrik Gutte; Adam Espe Hansen; Helle Hjorth Johannesen; Andreas Ettrup Clemmensen; Jan Henrik Ardenkjær-Larsen; Carsten Haagen Nielsen; Andreas Kjær
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

Review 6.  Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo.

Authors:  Peter C M van Zijl; Kevin Brindle; Hanzhang Lu; Peter B Barker; Richard Edden; Nirbhay Yadav; Linda Knutsson
Journal:  Curr Opin Chem Biol       Date:  2021-07-20       Impact factor: 8.972

7.  Simultaneous PET/MRI with (13)C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification.

Authors:  Adam E Hansen; Flemming L Andersen; Sarah T Henriksen; Alexandre Vignaud; Jan H Ardenkjaer-Larsen; Liselotte Højgaard; Andreas Kjaer; Thomas L Klausen
Journal:  EJNMMI Phys       Date:  2016-04-22

8.  Development of a Symmetric Echo-Planar Spectroscopy Imaging Framework for Hyperpolarized 13C Imaging in a Clinical PET/MR Scanner.

Authors:  Abubakr Eldirdiri; Stefan Posse; Lars G Hanson; Rie B Hansen; Pernille Holst; Christina Schøier; Annemarie T Kristensen; Helle Hjorth Johannesen; Andreas Kjaer; Adam E Hansen; Jan Henrik Ardenkjaer-Larsen
Journal:  Tomography       Date:  2018-09

Review 9.  Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology.

Authors:  John Kurhanewicz; Daniel B Vigneron; Jan Henrik Ardenkjaer-Larsen; James A Bankson; Kevin Brindle; Charles H Cunningham; Ferdia A Gallagher; Kayvan R Keshari; Andreas Kjaer; Christoffer Laustsen; David A Mankoff; Matthew E Merritt; Sarah J Nelson; John M Pauly; Philips Lee; Sabrina Ronen; Damian J Tyler; Sunder S Rajan; Daniel M Spielman; Lawrence Wald; Xiaoliang Zhang; Craig R Malloy; Rahim Rizi
Journal:  Neoplasia       Date:  2018-11-23       Impact factor: 5.715

10.  Analysis of 13 C and 14 C labeling in pyruvate and lactate in tumor and blood of lymphoma-bearing mice injected with 13 C- and 14 C-labeled pyruvate.

Authors:  E M Serrao; M I Kettunen; T B Rodrigues; D Y Lewis; F A Gallagher; D E Hu; K M Brindle
Journal:  NMR Biomed       Date:  2018-02-19       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.